利福平在耐多药肺结核肺切除术中的应用价值——第13组系列研究报告。C] - Suppr | 超能文献

利福平在耐多药肺结核肺切除术中的应用价值——第13组系列研究报告。C] - Suppr | 超能文献

相似文献

1

[Usefulness of rifampicin for pulmonary resection of drug-resistant pulmonary tuberculosis--report of the 13th series study. C].利福平在耐多药肺结核肺切除术中的应用价值——第13组系列研究报告。C]

Kekkaku. 1973 Jan;48(1):29-33.

2

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.肺切除术联合基于异烟肼和利福平的药物治疗用于耐多药和广泛耐药结核病患者。

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

3

Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.俄罗斯阿尔汉格尔斯克州肺结核患者分离出的结核分枝杆菌菌株的耐药性

Int J Tuberc Lung Dis. 2002 May;6(5):406-14.

4

[Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].[肺结核患者手术治疗及其病原体多重耐药性的有效性]

Probl Tuberk. 2000(4):24-6.

5

[Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].

Kekkaku. 1971 Nov;46(11):423-8.

6

[Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].[二线制剂乙胺丁醇和利福平在对基本抗结核药高度耐药的结核分枝杆菌所致实验性结核病中的活性]

Probl Tuberk. 1973;51(12):60-4.

7

Resistant mycobacterium tuberculosis: report of a family in Connecticut.耐药结核分枝杆菌：康涅狄格州一个家庭的报告。

Conn Med. 1980 Jul;44(7):416-8.

8

[Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].[化疗与静脉输注溶解臭氧同时使用时分枝杆菌耐药性的变化]

Probl Tuberk Bolezn Legk. 2004(7):32-5.

9

Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.利福平治疗耐药性结核分枝杆菌感染

N Engl J Med. 1970 Sep 17;283(12):616-21. doi: 10.1056/NEJM197009172831202.

10

[Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].

Bull Soc Pathol Exot. 1993;86(2):144-7.